eXoZymes, Inc.(EXOZ)

Biotechnology · Monrovia, CA

$5.55+0.03 (+0.54%)

Delayed quote: Oct 6, 2026, 2:58 PM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T19:47:11.323Z.

Stored calculation inputs

Calculation as of: 2026-10-06T19:47:11.323Z.

Quote observation: 2026-10-06T18:58:27.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 51,511,542
TTM operating cash flow · period ending 2026-06-30: -6,995,227

FMP input reference: 787788ea5c712995087b0511470a3bc1500b131fb4a88c1f5ff44ca2612ce4c8

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

EXOZ Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

EXOZ Competitors' Price/OCF Ratio

EXOZ

eXoZymes, Inc.

Current

Market Cap

$51.51M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs EXOZ

Market Cap

$51.39M

Price/OCF Ratio

2.11

TTM Avg

2.08

3Y Avg

4.49

5Y Avg

3.97

COCH

Envoy Medical, Inc.

vs EXOZ

Market Cap

$50.27M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLNN

Clene Inc.

vs EXOZ

Market Cap

$50.31M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs EXOZ

Market Cap

$50.58M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TENX

Tenax Therapeutics, Inc.

vs EXOZ

Market Cap

$50.53M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs EXOZ

Market Cap

$52.54M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ZYBT

Zhengye Biotechnology Holding Limited

vs EXOZ

Market Cap

$52.60M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RANI

Rani Therapeutics Holdings, Inc.

vs EXOZ

Market Cap

$53.03M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs EXOZ

Market Cap

$53.08M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
eXoZymes, Inc. (EXOZ)	$51.51M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$51.39M	2.11	2.08	4.49	3.97
Envoy Medical, Inc. (COCH)vs ›	$50.27M	N/A	N/A	N/A	N/A
Clene Inc. (CLNN)vs ›	$50.31M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$50.58M	N/A	N/A	N/A	N/A
Tenax Therapeutics, Inc. (TENX)vs ›	$50.53M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$52.54M	N/A	N/A	N/A	N/A
Zhengye Biotechnology Holding Limited (ZYBT)vs ›	$52.60M	N/A	N/A	N/A	N/A
Rani Therapeutics Holdings, Inc. (RANI)vs ›	$53.03M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$53.08M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

EXOZ Price/OCF Ratio Metrics

EXOZ Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics